posted on Dec, 4 2022 @ 08:33 PM
Been looking for some medical stuff concerning Myocarditis in Japanese Children. I said in a few previous posts that I would do some research/or talk
to a few doctors here in town about this subject. What I'm posting is basically being said with an internist here locally also. I'm still
researching stuff in Japanese that I'll have translated into English. Does seem like this should be a concern to ALL LOVING PARENTS.
As per finding: National Library of Medicine
As COVID-19 vaccines continue to be deployed worldwide, countries are now planning to vaccinate their pediatric populations as well. However, several
vaccine-related adverse events, including myocarditis, have been reported. Although the incidence of myocarditis after BNT162b2 vaccination is low, it
is higher, particularly after receiving the second dose, among young male recipients. A 13-year-old male adolescent presented with chest pain after
the second dose of the BNT162b2 vaccination. Electrocardiography, echocardiography, cardiac magnetic resonance imaging, and blood examinations were
consistent with myocarditis. He was treated conservatively because his symptoms were relatively mild. In Japan, it is expected that the chances of
diagnosing vaccine-related myocarditis will increase as more children are getting vaccinated. Our case report raises concerns to physicians that the
COVID-19 vaccination may cause rare cases of myocarditis, which must always be considered as a differential diagnosis.
Conclusions and relevance: In this small case series study, myocarditis was diagnosed in children after COVID-19 vaccination, most commonly in boys
after the second dose. In this case series, in short-term follow-up, patients were mildly affected. The long-term risks associated with
postvaccination myocarditis remain unknown. Larger studies with longer follow-up are needed to inform recommendations for COVID-19 vaccination in this
population.
A total of 747 vaccinated (first dose n = 326; second dose n = 421) and 6300 unvaccinated adolescents were included in analyses of short-term symptoms
and 32 vaccinated and 704 unvaccinated adolescents in long-term symptom analyses. In the first 14 days after the first and second vaccine dose the
most reported symptoms included headache and muscle or joint symptoms. In both vaccinated and unvaccinated adolescents, the 15-19-year-olds reported
significantly higher proportions of all symptoms compared to the 12-14-year-olds. After the second vaccine dose vaccinated 12-14-year-olds reported
significantly more headache in adjusted analyses (OR 2.20 (95% CI 1.24; 3.90)). Among the 15-19-year-olds, significantly more vaccinated adolescents
reported gastrointestinal symptoms (1.38 (1.06; 1.81)), headache (1.66 (1.24; 2.22)), and tiredness (1.44 (1.08; 1.93)). No differences were found in
long-term symptoms. Vaccinated adolescents reported significantly more short-term symptoms including headache, tiredness, and gastrointestinal
symptoms after the second vaccine dose than unvaccinated adolescents. Long-term symptom results should be interpreted with caution due to limited
sample size